BRPI0712393A2 - formas e processos polimórficos - Google Patents

formas e processos polimórficos Download PDF

Info

Publication number
BRPI0712393A2
BRPI0712393A2 BRPI0712393-0A BRPI0712393A BRPI0712393A2 BR PI0712393 A2 BRPI0712393 A2 BR PI0712393A2 BR PI0712393 A BRPI0712393 A BR PI0712393A BR PI0712393 A2 BRPI0712393 A2 BR PI0712393A2
Authority
BR
Brazil
Prior art keywords
formula
phenyl
trifluoromethyl
pyran
ylmethyl
Prior art date
Application number
BRPI0712393-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Kai Schiemann
Ulrich Emde
Tobias Schlueter
Christoph Saal
Michael Maiwald
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BRPI0712393A2 publication Critical patent/BRPI0712393A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0712393-0A 2006-06-19 2007-05-26 formas e processos polimórficos BRPI0712393A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06012525.9 2006-06-19
EP06012525 2006-06-19
PCT/EP2007/004711 WO2007147480A2 (en) 2006-06-19 2007-05-26 Polymorphic forms and process

Publications (1)

Publication Number Publication Date
BRPI0712393A2 true BRPI0712393A2 (pt) 2012-10-16

Family

ID=38687475

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0712393-0A BRPI0712393A2 (pt) 2006-06-19 2007-05-26 formas e processos polimórficos

Country Status (19)

Country Link
US (1) US8198452B2 (cg-RX-API-DMAC7.html)
EP (1) EP2032581B1 (cg-RX-API-DMAC7.html)
JP (1) JP5322928B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090020702A (cg-RX-API-DMAC7.html)
CN (1) CN101472928A (cg-RX-API-DMAC7.html)
AR (1) AR061379A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007263393B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712393A2 (cg-RX-API-DMAC7.html)
CA (1) CA2656064C (cg-RX-API-DMAC7.html)
EA (1) EA015994B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP099077A (cg-RX-API-DMAC7.html)
ES (1) ES2537759T3 (cg-RX-API-DMAC7.html)
IL (1) IL195844A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008016071A (cg-RX-API-DMAC7.html)
NZ (1) NZ574236A (cg-RX-API-DMAC7.html)
PE (1) PE20080337A1 (cg-RX-API-DMAC7.html)
TW (1) TW200815453A (cg-RX-API-DMAC7.html)
WO (1) WO2007147480A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200900383B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005027170A1 (de) * 2005-06-13 2006-12-14 Merck Patent Gmbh Substituierte Tetrahydrochinoline
DE102007021862A1 (de) * 2007-05-10 2008-11-13 Merck Patent Gmbh Wässrige pharmazeutische Zubereitung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3345355A1 (de) * 1983-12-15 1985-06-27 Hoechst Ag, 6230 Frankfurt Verfahren zur racematspaltung bicyclischer imino-(alpha)-carbonsaeureester
DE4203547A1 (de) * 1992-02-07 1993-08-12 Knoll Ag Verfahren zur racemattrennung von verapamil
JPH07247286A (ja) * 1994-01-18 1995-09-26 Sankyo Co Ltd 含窒素環状化合物の光学分割方法
JPH07330732A (ja) * 1994-06-10 1995-12-19 Kyorin Pharmaceut Co Ltd 光学活性な3−アミノ−1−ベンジルピペリジン誘導体
GB0010437D0 (en) * 2000-04-28 2000-06-14 Darwin Discovery Ltd Process
US20040002615A1 (en) * 2002-06-28 2004-01-01 Allen David Robert Preparation of chiral amino-nitriles
DK1761515T3 (da) * 2003-12-20 2009-02-16 Merck Patent Gmbh 2-(hetero-)aryl-substituerede tetrahydroquinolinderivater

Also Published As

Publication number Publication date
WO2007147480A3 (en) 2008-05-08
AR061379A1 (es) 2008-08-20
EP2032581A2 (en) 2009-03-11
PE20080337A1 (es) 2008-04-25
WO2007147480A2 (en) 2007-12-27
JP2009541231A (ja) 2009-11-26
AU2007263393B2 (en) 2012-03-01
EA200802400A1 (ru) 2009-06-30
ZA200900383B (en) 2010-01-27
KR20090020702A (ko) 2009-02-26
NZ574236A (en) 2010-11-26
TW200815453A (en) 2008-04-01
US20090176820A1 (en) 2009-07-09
EA015994B1 (ru) 2012-01-30
ES2537759T3 (es) 2015-06-11
CA2656064C (en) 2013-11-05
JP5322928B2 (ja) 2013-10-23
MX2008016071A (es) 2009-01-15
CA2656064A1 (en) 2007-12-27
ECSP099077A (es) 2009-02-27
EP2032581B1 (en) 2015-03-11
CN101472928A (zh) 2009-07-01
US8198452B2 (en) 2012-06-12
IL195844A0 (en) 2009-09-01
AU2007263393A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
MX2011006000A (es) Compuestos para tratar cancer.
NZ524404A (en) Indole derivatives and their use as medicaments
CN116964044B (zh) 乙酰胺基-苯基四唑衍生物及其使用方法
EP4058458A2 (en) Novel functionalized lactones as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
CN1807413B (zh) 咔唑磺酰胺衍生物及其制备方法
KR20110136888A (ko) 퀴녹살린 유도체 및 양성 및 악성 종양 질병 치료를 위한 이의 용도
CN114685520B (zh) 三并环化合物及其药物组合物和应用
CA2656064C (en) Polymorphic forms and process
JP2006522012A (ja) ベンゾキサゾシンおよびそのモノアミン再吸収阻害剤としての用途
EP2994122A1 (en) Novel transcription factor modulators
JP2015531382A (ja) ピロリジン
BRPI0611613A2 (pt) tetraidroquinolinas substituìdas
CN119143734A (zh) 作为at2r拮抗剂的杂环化合物及其用途
CN108017643A (zh) 一种含有氮杂环螺旋结构的高效ido/tdo双抑制剂
CN110467601A (zh) 一种吡唑联吡啶酮类化合物、中间体及其制备方法及应用
JP5236743B2 (ja) テトラヒドロキノリン誘導体の調製方法
CN113444078B (zh) 抗凋亡蛋白Bcl-2抑制剂及其制备方法和应用
HK1135380A (en) Polymorphic forms and process
CN104016878B (zh) 芳基乙酸类衍生物、其制备方法及其医药用途
CN119330953A (zh) 雄激素受体调节剂的偶联物及其制备方法
TW202527947A (zh) 芳香醯肼類衍生物及其醫藥用途
JP2001514653A (ja) ヘテロ環状物質
WO2019141095A1 (zh) 脒类和胍类衍生物、其制备方法及其在医药上的应用
HK1117829A (en) Indole derivatives having antitumor activity

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2229 DE 24/09/2013.